Article
Unveiling intratumoral heterogeneity and isocitrate dehydrogenase status in gliomas: a simultaneous fluorine-18 fluorodeoxyglucose PET/MRI study based on 2021 WHO classification.
Nuclear medicine communications - 1 Jul 2026
Şeker Kerim, Çeltikçi Emrah, Aydos Uğuray, İnan Mehmet Arda, Ateş Seda Gülbahar, Şahin Mustafa Çağlar, Akdemir Ümit Özgür, Atay Lütfiye Özlem
Abstract excerpt
OBJECTIVES: To evaluate the diagnostic utility of simultaneous fluorine-18 fluorodeoxyglucose ( 18 F-FDG) PET/MRI quantitative parameters in characterizing glioma heterogeneity and predicting isocitrate dehydrogenase (IDH) mutation status, based on the 2021 WHO Classification. METHODS: Twenty-five patients with histopathologically confirmed gliomas underwent preoperative simultaneous 18 F-FDG PET/MRI. Forty-one...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.